Two new xanthone-anthraquinone heterodimers, acremoxanthone C (5) and acremoxanthone D (2), have been isolated from an extract of an unidentified fungus of the order Hypocreales (MSX 17022) by bioactivity-directed fractionation as part of a search for anticancer leads from filamentous fungi. Two known related compounds, acremonidin A (4) and acremonidin C (3) were also isolated, as was a known benzophenone, moniliphenone (1). The structures of these isolates were determined via extensive use of spectroscopic and spectrometric tools in conjunction with comparisons to the literature. All compounds (1-5) were evaluated against a suite of biological assays, including those for cytotoxicity, inhibition of the 20S proteasome, mitochondrial transmembrane potential and nuclear factor-B. © 2012 Japan Antibiotics Research Association All rights reserved.
CITATION STYLE
Ayers, S., Graf, T. N., Adcock, A. F., Kroll, D. J., Shen, Q., Swanson, S. M., … Oberlies, N. H. (2012). Cytotoxic xanthone-anthraquinone heterodimers from an unidentified fungus of the order Hypocreales (MSX 17022). Journal of Antibiotics, 65(1), 3–8. https://doi.org/10.1038/ja.2011.95
Mendeley helps you to discover research relevant for your work.